Related Experiment Videos

[Transforming growth factor-beta signaling and cancer]

K Miyazono1

  • 1Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan.

Human Cell
|February 24, 2001
PubMed

Insights

Transforming growth factor-beta (TGF-beta) inhibits cell growth and causes fibrosis. Dysregulation of its signaling pathway, including negative regulators, contributes to cancer development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Context:

  • Transforming growth factor-beta (TGF-beta) is a key cytokine regulating cell growth, differentiation, and tissue homeostasis.
  • TGF-beta exerts its functions by binding to serine/threonine kinase receptors, initiating intracellular signaling cascades.
  • The TGF-beta/Smad pathway is crucial for normal cellular processes, and its dysregulation is implicated in various diseases.

Purpose:

  • To elucidate the role of TGF-beta signaling in cellular processes.
  • To investigate the mechanisms by which TGF-beta regulates cell growth and fibrosis.
  • To understand the contribution of TGF-beta pathway perturbations to tumorigenesis.

Summary:

  • TGF-beta is a multifunctional cytokine that inhibits cell proliferation and promotes fibrosis.
  • Activation of TGF-beta signaling occurs through specific cell surface receptors, leading to the activation of Smad proteins.
  • Aberrant TGF-beta/Smad signaling, potentially due to defects in negative regulators like inhibitory Smads and corepressors, is linked to the development of various cancers.

Impact:

  • Understanding TGF-beta signaling is critical for developing therapeutic strategies against fibrosis and cancer.
  • Identifying the role of negative regulators in TGF-beta pathway dysfunction offers potential targets for cancer therapy.
  • This research contributes to the fundamental knowledge of cell signaling and its implications in disease pathogenesis.

Related Concept Videos